Cann Group Limited (ASX:CAN)

Market Cap	8.30M +13.7%
Revenue (ttm)	9.65M -27.2%
Net Income	20.30M
EPS	0.02
Shares Out	1.66B
PE Ratio	0.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	927,720
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0020 - 0.0230
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 4, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error